Holen Sie sich die Stockscreener-App
2.42
4.72%
-0.12
Vorhandelsmarkt:
2.40
-0.02
-0.83%
Schlusskurs vom Vortag:
$2.54
Offen:
$2.51
24-Stunden-Volumen:
501.61K
Relative Volume:
0.85
Marktkapitalisierung:
$90.83M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-11.68%
1M Leistung:
-8.68%
6M Leistung:
+50.31%
1J Leistung:
+14.69%
1-Tages-Spanne:
$2.34
$2.55
1-Wochen-Bereich:
$2.322
$2.78
52-Wochen-Spanne:
$1.23
$4.92
Metagenomi Inc Stock (MGX) Company Profile
Firmenname
Metagenomi Inc
Sektor
Branche
Telefon
(510) 871-4880
Adresse
5959 HORTON STREET, EMERYVILLE
Vergleichen Sie MGX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MGX
Metagenomi Inc
|
2.42 | 95.33M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Metagenomi Inc Stock (MGX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-05-07 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-05-02 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-03-05 | Eingeleitet | BMO Capital Markets | Outperform |
| 2024-03-05 | Eingeleitet | Chardan Capital Markets | Buy |
| 2024-03-05 | Eingeleitet | JP Morgan | Overweight |
| 2024-03-05 | Eingeleitet | Jefferies | Buy |
| 2024-03-05 | Eingeleitet | TD Cowen | Outperform |
| 2024-03-05 | Eingeleitet | Wells Fargo | Overweight |
Alle ansehen
Metagenomi Inc Aktie (MGX) Neueste Nachrichten
How to forecast Metagenomi Inc. trends using time series2025 Earnings Surprises & Stock Portfolio Risk Control - newser.com
Is Metagenomi Inc. stock gaining market shareJuly 2025 PreEarnings & Stepwise Entry and Exit Trade Signals - newser.com
Will Metagenomi Inc. stock gain from lower inflation2025 Price Momentum & Reliable Volume Spike Trade Alerts - newser.com
Is Metagenomi Inc. stock a safe haven assetWeekly Market Outlook & Smart Investment Allocation Tips - newser.com
Is Metagenomi Inc a good long term investmentEconomic Impact on Stocks & Start Building Capital with Zero Risk - earlytimes.in
Using AI based signals to follow Metagenomi Inc.July 2025 Trade Ideas & Verified Entry Point Detection - newser.com
Market reaction to Metagenomi Inc.’s recent newsBull Run & Technical Confirmation Trade Alerts - newser.com
What indicators show strength in Metagenomi Inc.2025 Momentum Check & Free Expert Verified Stock Movement Alerts - newser.com
Is Metagenomi Inc. stock a bargain at current levelsPortfolio Value Summary & High Yield Stock Recommendations - newser.com
What sentiment indicators say about Metagenomi Inc. stockEntry Point & Community Verified Trade Signals - newser.com
How to manage a losing position in Metagenomi Inc.Weekly Gains Summary & Free Technical Pattern Based Buy Signals - newser.com
Dropping Nvidia for Amazon's custom chips helped gene therapy startup Metagenomi cut AI bill 56% - MSN
Key resistance and support levels for Metagenomi Inc.Portfolio Growth Summary & Accurate Entry and Exit Point Alerts - newser.com
Will Metagenomi Inc. stock go up soon2025 Top Decliners & Entry Point Confirmation Alerts - newser.com
Weiss Ratings Reiterates Sell (E+) Rating for Metagenomi (NASDAQ:MGX) - MarketBeat
How to build a custom watchlist for Metagenomi Inc.Portfolio Growth Summary & Momentum Based Trading Signals - newser.com
Is Metagenomi Inc. forming a reversal patternMarket Rally & Safe Entry Trade Reports - newser.com
Exit strategy if you’re trapped in Metagenomi Inc.Market Volume Report & Growth Focused Investment Plans - newser.com
How to monitor Metagenomi Inc. with trend dashboardsRate Cut & Verified Momentum Stock Ideas - newser.com
Metagenomi Inc Stock Analysis and ForecastDebt-to-Equity Ratio Analysis & Stay One Step Ahead of Risk Events - earlytimes.in
Finanzdaten der Metagenomi Inc-Aktie (MGX)
Es liegen keine Finanzdaten für Metagenomi Inc (MGX) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):